Cibus (CBUS) EPS (Basic) Growth (3y) (2019 - 2026)
Cibus (CBUS) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -38.31% |
| 10 | Cibus | 132.79 Mn | 112.36 Mn | - | 55.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.81% |
| Dec 31, 2025 | 39.05% |
| Sep 30, 2025 | 58.36% |
| Jun 30, 2025 | 37.89% |
| Mar 31, 2025 | 40.49% |
| Dec 31, 2024 | 50.95% |
| Sep 30, 2024 | 4.48% |
| Jun 30, 2024 | 41.35% |
| Mar 31, 2024 | 54.25% |
| Dec 31, 2023 | -10.78% |
| Sep 30, 2023 | 47.42% |
| Jun 30, 2023 | 41.27% |
| Mar 31, 2023 | 31.21% |
| Dec 31, 2022 | 45.01% |
| Sep 30, 2022 | 26.83% |
| Jun 30, 2022 | 42.98% |
| Mar 31, 2022 | 16.01% |
| Dec 31, 2021 | 11.96% |
| Sep 30, 2021 | 5.34% |
| Jun 30, 2021 | 20.16% |